284 related articles for article (PubMed ID: 15681520)
41. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
Vehmanen L; Elomaa I; Blomqvist C; Saarto T
J Clin Oncol; 2006 Feb; 24(4):675-80. PubMed ID: 16446340
[TBL] [Abstract][Full Text] [Related]
42. Cancer and its treatment effect on young breast cancer survivors.
Camp-Sorrell D
Semin Oncol Nurs; 2009 Nov; 25(4):251-8. PubMed ID: 19879431
[TBL] [Abstract][Full Text] [Related]
43. Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial.
Adjuvant Breast Cancer Trials Collaborative Group
J Natl Cancer Inst; 2007 Apr; 99(7):516-25. PubMed ID: 17405996
[TBL] [Abstract][Full Text] [Related]
44. Infertility induced by cancer treatment: inappropriate or no information provided to majority of French survivors of cancer.
Mancini J; Rey D; Préau M; Malavolti L; Moatti JP
Fertil Steril; 2008 Nov; 90(5):1616-25. PubMed ID: 18054004
[TBL] [Abstract][Full Text] [Related]
45. [Survey on oncologists-provided information on treatment-related infertility to breast cancer patients].
Kubo A; Koido K; Sawada M; Ryushima Y; Shimizu C; Kato T; Ando M; Kinoshita T; Murakoshi K; Yokote N; Fujiwara Y; Yamamoto H
Gan To Kagaku Ryoho; 2012 Mar; 39(3):399-403. PubMed ID: 22421767
[TBL] [Abstract][Full Text] [Related]
46. Emerging bone health issues in women with breast cancer in Hawai'i.
Carney JF; Davis J
Hawaii Med J; 2007 Jun; 66(6):164-6. PubMed ID: 17621865
[TBL] [Abstract][Full Text] [Related]
47. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
Groenvold M; Fayers PM; Petersen MA; Mouridsen HT
Breast Cancer Res Treat; 2006 Aug; 98(3):275-84. PubMed ID: 16541325
[TBL] [Abstract][Full Text] [Related]
48. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk.
Patt DA; Duan Z; Fang S; Hortobagyi GN; Giordano SH
J Clin Oncol; 2007 Sep; 25(25):3871-6. PubMed ID: 17664457
[TBL] [Abstract][Full Text] [Related]
49. Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
Gnant MF; Mlineritsch B; Luschin-Ebengreuth G; Grampp S; Kaessmann H; Schmid M; Menzel C; Piswanger-Soelkner JC; Galid A; Mittlboeck M; Hausmaninger H; Jakesz R;
J Clin Oncol; 2007 Mar; 25(7):820-8. PubMed ID: 17159195
[TBL] [Abstract][Full Text] [Related]
50. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy.
Navari RM; Brenner MC; Wilson MN
Breast Cancer Res Treat; 2008 Nov; 112(1):197-201. PubMed ID: 18064563
[TBL] [Abstract][Full Text] [Related]
51. Is adjuvant therapy for older patients with node (+) early breast cancer cost-effective?
Naeim A; Keeler EB
Breast Cancer Res Treat; 2005 Nov; 94(2):95-103. PubMed ID: 16261407
[TBL] [Abstract][Full Text] [Related]
52. Ovarian function, reproduction and strategies for fertility preservation after breast cancer.
Tomao F; Spinelli GP; Panici PB; Frati L; Tomao S
Crit Rev Oncol Hematol; 2010 Oct; 76(1):1-12. PubMed ID: 20185328
[TBL] [Abstract][Full Text] [Related]
53. Sexual problems in younger women after breast cancer surgery.
Burwell SR; Case LD; Kaelin C; Avis NE
J Clin Oncol; 2006 Jun; 24(18):2815-21. PubMed ID: 16782919
[TBL] [Abstract][Full Text] [Related]
54. [Breast cancer in young women: epidemiology and treatment dilemmas].
van der Sangen MJ; Voogd AC; van de Poll-Franse LV; Tjan-Heijnen VC
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2495-500. PubMed ID: 19055255
[TBL] [Abstract][Full Text] [Related]
55. Is mode of breast cancer detection associated with cancer treatment in the United States?
Yabroff KR; Harlan LC; Clegg LX; Ballard-Barbash R; Stevens J; Weaver DL
Cancer; 2008 Mar; 112(5):1011-9. PubMed ID: 18189297
[TBL] [Abstract][Full Text] [Related]
56. Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer.
Duric VM; Butow PN; Sharpe L; Heritier S; Boyle F; Beith J; Wilcken NR; Coates AS; Simes RJ; Stockler MR
Patient Educ Couns; 2008 Aug; 72(2):239-45. PubMed ID: 18434070
[TBL] [Abstract][Full Text] [Related]
57. The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma.
Oestreicher N; Ramsey SD; McCune JS; Linden HM; Veenstra DL
Cancer; 2005 Nov; 104(10):2054-62. PubMed ID: 16216002
[TBL] [Abstract][Full Text] [Related]
58. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
59. Menopausal hormone therapy (HT) in patients with breast cancer.
Batur P; Blixen CE; Moore HC; Thacker HL; Xu M
Maturitas; 2006 Jan; 53(2):123-32. PubMed ID: 16368466
[TBL] [Abstract][Full Text] [Related]
60. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.
Elkin EB; Hurria A; Mitra N; Schrag D; Panageas KS
J Clin Oncol; 2006 Jun; 24(18):2757-64. PubMed ID: 16782916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
